{"id":"https://openalex.org/W4367296748","doi":"https://doi.org/10.1016/j.eururo.2023.03.030","title":"Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial","display_name":"Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial","publication_year":2023,"publication_date":"2023-04-28","ids":{"openalex":"https://openalex.org/W4367296748","doi":"https://doi.org/10.1016/j.eururo.2023.03.030","pmid":"https://pubmed.ncbi.nlm.nih.gov/37121850"},"language":"en","primary_location":{"id":"doi:10.1016/j.eururo.2023.03.030","doi":"https://doi.org/10.1016/j.eururo.2023.03.030","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.eururo.2023.03.030","pdf_url":null,"source":{"id":"https://openalex.org/S96871409","display_name":"European Urology","issn_l":"0302-2838","issn":["0302-2838","1421-993X","1873-7560"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Urology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.eururo.2023.03.030","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026717218","display_name":"Petros D. Grivas","orcid":"https://orcid.org/0000-0003-3965-3394","observed_orcids":["https://orcid.org/0000-0003-3965-3394"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Petros Grivas","raw_affiliation_strings":["Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA. Electronic address: pgrivas@uw.edu","Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA. Electronic address: pgrivas@uw.edu","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057146015","display_name":"Se Hoon Park","orcid":"https://orcid.org/0000-0001-5084-9326","observed_orcids":["https://orcid.org/0000-0001-5084-9326"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]},{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Se Hoon Park","raw_affiliation_strings":["Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea","institution_ids":["https://openalex.org/I2802194831","https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006671522","display_name":"\u00c9ric Voog","orcid":"https://orcid.org/0000-0001-8366-8003","observed_orcids":["https://orcid.org/0000-0001-8366-8003"]},"institutions":[{"id":"https://openalex.org/I4210123491","display_name":"Centre Jean Bernard","ror":"https://ror.org/02s2qzh96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210123491"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Eric Voog","raw_affiliation_strings":["Centre Jean Bernard Clinique Victor Hugo, Le Mans, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Jean Bernard Clinique Victor Hugo, Le Mans, France","institution_ids":["https://openalex.org/I4210123491"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064767706","display_name":"Claudia Caserta","orcid":"https://orcid.org/0009-0003-3721-4520","observed_orcids":["https://orcid.org/0009-0003-3721-4520"]},"institutions":[{"id":"https://openalex.org/I4210123105","display_name":"Azienda Ospedaliera S.Maria","ror":"https://ror.org/02t96cy48","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210123105"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Claudia Caserta","raw_affiliation_strings":["Medical Oncology Unit, Azienda Ospedaliera S. Maria, Terni, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, Azienda Ospedaliera S. Maria, Terni, Italy","institution_ids":["https://openalex.org/I4210123105"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041526616","display_name":"Howard Gurney","orcid":"https://orcid.org/0000-0003-0217-5261","observed_orcids":["https://orcid.org/0000-0003-0217-5261"]},"institutions":[{"id":"https://openalex.org/I99043593","display_name":"Macquarie University","ror":"https://ror.org/01sf06y89","country_code":"AU","type":"education","lineage":["https://openalex.org/I99043593"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Howard Gurney","raw_affiliation_strings":["Department of Clinical Medicine, Macquarie University, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Medicine, Macquarie University, Sydney, Australia","institution_ids":["https://openalex.org/I99043593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074756323","display_name":"Joaquim Bellmunt B","orcid":"https://orcid.org/0000-0003-2328-3421","observed_orcids":["https://orcid.org/0000-0003-2328-3421","https://orcid.org/0000-0001-7569-7074"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joaquim Bellmunt","raw_affiliation_strings":["Department of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060795077","display_name":"Haralabos P. Kalofonos","orcid":"https://orcid.org/0000-0002-3286-778X","observed_orcids":["https://orcid.org/0000-0002-3286-778X"]},"institutions":[{"id":"https://openalex.org/I2801754460","display_name":"General University Hospital of Patras","ror":"https://ror.org/03c3d1v10","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I2801754460"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Haralabos Kalofonos","raw_affiliation_strings":["Medical Oncology, University General Hospital of Patras, Patras, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University General Hospital of Patras, Patras, Greece","institution_ids":["https://openalex.org/I2801754460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088582666","display_name":"Anders Ull\u00e9n","orcid":"https://orcid.org/0000-0002-9023-3259","observed_orcids":["https://orcid.org/0000-0002-9023-3259"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Anders Ull\u00e9n","raw_affiliation_strings":["Department of Pelvic Cancer, Genitourinary Oncology Unit, Karolinska University Hospital, Solna, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pelvic Cancer, Genitourinary Oncology Unit, Karolinska University Hospital, Solna, Sweden","institution_ids":["https://openalex.org/I1335113835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027991868","display_name":"Yohann Loriot","orcid":"https://orcid.org/0000-0002-8338-1739","observed_orcids":["https://orcid.org/0000-0002-8338-1739"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Yohann Loriot","raw_affiliation_strings":["INSERM U981, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U981, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I277688954","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044972820","display_name":"Srikala S. Sridhar","orcid":"https://orcid.org/0000-0002-6994-1285","observed_orcids":["https://orcid.org/0000-0002-6994-1285"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Srikala S. Sridhar","raw_affiliation_strings":["Princess Margaret Cancer Center, University Health Network, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Center, University Health Network, Toronto, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071744718","display_name":"Yoshiaki Yamamoto","orcid":"https://orcid.org/0000-0002-8452-448X","observed_orcids":["https://orcid.org/0000-0002-8452-448X"]},"institutions":[{"id":"https://openalex.org/I4210118520","display_name":"Yamaguchi University Hospital","ror":"https://ror.org/02dgmxb18","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210118520"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiaki Yamamoto","raw_affiliation_strings":["Yamaguchi University Hospital, Ube, Yamaguchi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yamaguchi University Hospital, Ube, Yamaguchi, Japan","institution_ids":["https://openalex.org/I4210118520"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050042851","display_name":"Daniel Peter Petrylak","orcid":"https://orcid.org/0000-0001-6165-5797","observed_orcids":["https://orcid.org/0000-0001-6165-5797"]},"institutions":[{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel P. Petrylak","raw_affiliation_strings":["Yale Cancer Center, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale Cancer Center, New Haven, CT, USA","institution_ids":["https://openalex.org/I2802730090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004985848","display_name":"Cora Nanette Sternberg","orcid":"https://orcid.org/0000-0003-3938-2627","observed_orcids":["https://orcid.org/0000-0003-3938-2627"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cora N. Sternberg","raw_affiliation_strings":["Weill Cornell Medicine, Hematology/Oncology, Englander Institute for Precision Medicine, Meyer Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine, Hematology/Oncology, Englander Institute for Precision Medicine, Meyer Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017229890","display_name":"Shilpa Gupta","orcid":"https://orcid.org/0000-0002-8775-503X","observed_orcids":["https://orcid.org/0000-0002-8775-503X"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shilpa Gupta","raw_affiliation_strings":["Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046444872","display_name":"Bo Huang","orcid":"https://orcid.org/0000-0002-3088-9328","observed_orcids":["https://orcid.org/0000-0002-3088-9328"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bo Huang","raw_affiliation_strings":["Pfizer, Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015679960","display_name":"Nuno Matos Costa","orcid":"https://orcid.org/0009-0003-0676-2065","observed_orcids":["https://orcid.org/0009-0003-0676-2065"]},"institutions":[{"id":"https://openalex.org/I4405254080","display_name":"Pfizer (Portugal)","ror":"https://ror.org/01ctjz153","country_code":"PT","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4405254080"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Nuno Costa","raw_affiliation_strings":["Pfizer, Porto Salvo, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Porto Salvo, Portugal","institution_ids":["https://openalex.org/I4405254080"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112751347","display_name":"Robert J Laliberte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J. Laliberte","raw_affiliation_strings":["Pfizer, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Cambridge, MA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108751899","display_name":"Alessandra di Pietro","orcid":"https://orcid.org/0009-0009-1887-6610","observed_orcids":["https://orcid.org/0009-0009-1887-6610"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alessandra di Pietro","raw_affiliation_strings":["Pfizer srl, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer srl, Milano, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048855238","display_name":"Bego\u00f1a P. Valderrama","orcid":"https://orcid.org/0000-0003-0175-1263","observed_orcids":["https://orcid.org/0000-0003-0175-1263"]},"institutions":[{"id":"https://openalex.org/I4210153139","display_name":"Hospital Universitario Virgen del Roc\u00edo","ror":"https://ror.org/04vfhnm78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210153139"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Bego\u00f1a P. Valderrama","raw_affiliation_strings":["Department of Medical Oncology, Hospital Universitario Virgen del Roc\u00edo, Sevilla, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Universitario Virgen del Roc\u00edo, Sevilla, Spain","institution_ids":["https://openalex.org/I4210153139"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089861374","display_name":"Thomas B. Powles","orcid":"https://orcid.org/0000-0001-7760-4724","observed_orcids":["https://orcid.org/0000-0001-7760-4724"]},"institutions":[{"id":"https://openalex.org/I1307195382","display_name":"St Bartholomew's Hospital","ror":"https://ror.org/00nh9x179","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]},{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Thomas Powles","raw_affiliation_strings":["Barts Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London, St. Bartholomew's Hospital, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barts Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London, St. Bartholomew's Hospital, London, UK","institution_ids":["https://openalex.org/I1307195382","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]}],"institutions":[],"countries_distinct_count":12,"institutions_distinct_count":26,"corresponding_author_ids":["https://openalex.org/A5026717218"],"corresponding_institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"],"apc_list":{"value":5250,"currency":"USD","value_usd":5250},"apc_paid":{"value":5250,"currency":"USD","value_usd":5250},"fwci":14.4459,"has_fulltext":false,"cited_by_count":66,"citation_normalized_percentile":{"value":0.99467114,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"84","issue":"1","first_page":"95","last_page":"108"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12695","display_name":"Urinary and Genital Oncology Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/avelumab","display_name":"avelumab","score":0.9950000047683716},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.7450000047683716},{"id":"https://openalex.org/keywords/advanced-urothelial-carcinoma","display_name":"advanced urothelial carcinoma","score":0.9810000061988831},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.902999997138977},{"id":"https://openalex.org/keywords/javelin-bladder-100","display_name":"JAVELIN Bladder 100","score":0.9459999799728394},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.5659999847412109},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7170000076293945},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":1.0},{"id":"https://openalex.org/keywords/best-supportive-care","display_name":"best supportive care","score":0.765999972820282},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.8360000252723694},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.6000000238418579},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.9729999899864197},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.7200000286102295},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6499999761581421},{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.5019999742507935},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9358759522438049},{"id":"https://openalex.org/C2780548848","wikidata":"https://www.wikidata.org/wiki/Q2290212","display_name":"Javelin","level":3,"score":0.9074556827545166},{"id":"https://openalex.org/C2777381376","wikidata":"https://www.wikidata.org/wiki/Q21083261","display_name":"Avelumab","level":5,"score":0.8472138047218323},{"id":"https://openalex.org/C3019882237","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Urothelial carcinoma","level":4,"score":0.7225486040115356},{"id":"https://openalex.org/C2911057145","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Metastatic Urothelial Carcinoma","level":5,"score":0.692383885383606},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5582839250564575},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5540350675582886},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.46822497248649597},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.46318838000297546},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.43193256855010986},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.4003680944442749},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.36739596724510193},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2530241012573242},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.1420278251171112},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.11438578367233276},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C207451115","wikidata":"https://www.wikidata.org/wiki/Q12898216","display_name":"Throwing","level":2,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001743","descriptor_name":"Urinary Bladder","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002295","descriptor_name":"Carcinoma, Transitional Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.eururo.2023.03.030","doi":"https://doi.org/10.1016/j.eururo.2023.03.030","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.eururo.2023.03.030","pdf_url":null,"source":{"id":"https://openalex.org/S96871409","display_name":"European Urology","issn_l":"0302-2838","issn":["0302-2838","1421-993X","1873-7560"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Urology","raw_type":"journal-article"},{"id":"pmid:37121850","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37121850","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European urology","raw_type":"Randomized Controlled Trial"}],"best_oa_location":{"id":"doi:10.1016/j.eururo.2023.03.030","doi":"https://doi.org/10.1016/j.eururo.2023.03.030","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.eururo.2023.03.030","pdf_url":null,"source":{"id":"https://openalex.org/S96871409","display_name":"European Urology","issn_l":"0302-2838","issn":["0302-2838","1421-993X","1873-7560"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Urology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1857682357","https://openalex.org/W2152762320","https://openalex.org/W2559804019","https://openalex.org/W2760661635","https://openalex.org/W2903848939","https://openalex.org/W3024551702","https://openalex.org/W3036701611","https://openalex.org/W3087464965","https://openalex.org/W3118924526","https://openalex.org/W3121561670","https://openalex.org/W3133799984","https://openalex.org/W3164197656","https://openalex.org/W3169535309","https://openalex.org/W3209393335","https://openalex.org/W4200026971","https://openalex.org/W4213072175"],"related_works":["https://openalex.org/W4286295522","https://openalex.org/W3087874197","https://openalex.org/W3168444608","https://openalex.org/W4387595262","https://openalex.org/W4324136701","https://openalex.org/W4362576035","https://openalex.org/W4213072175","https://openalex.org/W4310753917","https://openalex.org/W4366339435","https://openalex.org/W4286298696"],"abstract_inverted_index":{"BACKGROUND:":[0],"In":[1,250],"the":[2,138,198,226,251,270],"phase":[3],"3":[4],"JAVELIN":[5,58,252],"Bladder":[6,59,253],"100":[7,254],"trial,":[8],"avelumab":[9,86,231,259],"first-line":[10],"(1L)":[11],"maintenance":[12,233,256],"+":[13,78,87,153],"best":[14,163],"supportive":[15],"care":[16],"(BSC)":[17],"significantly":[18],"prolonged":[19],"overall":[20,227],"survival":[21,25],"(OS)":[22],"and":[23,127,133,141,160,201,215],"progression-free":[24,39,243],"(PFS)":[26],"versus":[27],"BSC":[28,88,93],"alone":[29,94],"in":[30,48,103,131,217],"patients":[31,161,238],"with":[32,66,151,223,239,258,266],"advanced":[33,69,267],"urothelial":[34],"carcinoma":[35],"(aUC)":[36],"who":[37,241],"were":[38,82,129,192,221],"following":[40,244],"1L":[41,76,232,245],"platinum-based":[42,246],"chemotherapy,":[43],"leading":[44],"to":[45,84,165,273],"regulatory":[46],"approval":[47],"various":[49],"countries.":[50],"OBJECTIVE:":[51],"To":[52],"analyze":[53],"clinically":[54,218],"relevant":[55,219],"subgroups":[56,136,220],"from":[57],"100.":[60],"DESIGN,":[61],"SETTING,":[62],"AND":[63,121,147],"PARTICIPANTS:":[64],"Patients":[65],"unresectable":[67],"locally":[68],"or":[70,80,92,183],"metastatic":[71],"UC":[72],"without":[73,205],"progression":[74],"on":[75,115],"gemcitabine":[77,154],"cisplatin":[79],"carboplatin":[81,152],"randomized":[83],"receive":[85],"(n":[89,95],"=":[90,96],"350)":[91],"350).":[97],"Median":[98],"follow-up":[99],"was":[100,167],">19":[101],"mo":[102],"both":[104],"arms":[105],"(data":[106],"cutoff":[107],"October":[108],"21,":[109],"2019).":[110],"This":[111],"trial":[112],"is":[113],"registered":[114],"ClinicalTrials.gov":[116],"as":[117,234],"NCT02603432.":[118],"OUTCOME":[119],"MEASUREMENTS":[120],"STATISTICAL":[122],"ANALYSIS:":[123],"OS":[124,214],"(primary":[125],"endpoint)":[126],"PFS":[128,216],"analyzed":[130],"protocol-specified":[132],"post":[134,202],"hoc":[135,203],"using":[137],"Kaplan-Meier":[139],"method":[140],"Cox":[142],"proportional":[143],"hazards":[144],"models.":[145],"RESULTS":[146],"LIMITATIONS:":[148],"tumors":[149],"treated":[150],"(HR":[155,171,178,186],"0.67,":[156],"95%":[157,173,180,188],"CI":[158,174,181,189],"0.39-1.14),":[159],"whose":[162],"response":[164,170,177],"chemotherapy":[166],"a":[168],"complete":[169],"0.80,":[172],"0.46-1.37),":[175],"partial":[176],"0.62,":[179],"0.46-0.84),":[182],"stable":[184],"disease":[185],"0.70,":[187],"0.46-1.06).":[190],"Observations":[191],"similar":[193],"for":[194,208,225,237],"PFS.":[195],"Limitations":[196],"include":[197],"smaller":[199],"size":[200],"evaluation":[204],"multiplicity":[206],"adjustment":[207],"some":[209],"subgroups.":[210],"CONCLUSIONS:":[211],"Analyses":[212],"of":[213,264,269],"consistent":[222],"results":[224],"population,":[228],"further":[229],"supporting":[230],"standard-of-care":[235],"treatment":[236,257],"aUC":[240],"are":[242],"chemotherapy.":[247],"PATIENT":[248],"SUMMARY:":[249],"study,":[255],"helped":[260],"many":[261],"different":[262],"groups":[263],"people":[265],"cancer":[268],"urinary":[271],"tract":[272],"live":[274],"longer.":[275]},"counts_by_year":[{"year":2026,"cited_by_count":14},{"year":2025,"cited_by_count":18},{"year":2024,"cited_by_count":27},{"year":2023,"cited_by_count":7}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2023-04-29T00:00:00"}